EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hypoxia signaling in cancer: Implications for therapeutic interventions

Yan Zhuang, Kua Liu, Qinyu He, Xiaosong Gu, Chunping Jiang, Junhua Wu

MedComm · 2023-02 · 4 (1)

DOI: 10.1002/mco2.203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 23.01.2023. Verfasst von Yan Zhuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology National Institute of Healthcare Data Science at Nanjing University Jiangsu Key Laboratory of Mo…. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 461 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is a persistent physiological feature of many different solid tumors and a key driver of malignancy, and in recent years, it has been recognized as an important target for cancer therapy. Hypoxia occurs in the majority of solid tumors due to a poor vascular oxygen supply that is not sufficient to meet the needs of rapidly proliferating cancer cells. A hypoxic tumor microenvironment (TME) can reduce the effectiveness of other tumor therapies, such as radiotherapy, chemotherapy, and immunotherapy. In this review, we discuss the critical role of hypoxia in tumor development, including tumor metabolism, tumor immunity, and tumor angiogenesis. The treatment methods for hypoxic TME are summarized, including hypoxia‐targeted therapy and improving oxygenation by alleviating tumor hypoxia itself. Hyperoxia therapy can be used to improve tissue oxygen partial pressure and relieve tumor hypoxia. We focus on the underlying mechanisms of hyperoxia and their impact on current cancer therapies and discuss the prospects of hyperoxia therapy in cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

hyperoxiahypoxia‐inducible factor (HIF)immunotherapytargeted theraphytumor hypoxia

Autor:innen und Institutionen

  • State Key Laboratory of Pharmaceutical Biotechnology National Institute of Healthcare Data Science at Nanjing University Jiangsu Key Laboratory of Molecular Medicine Medicine Medical School of Nanjing University Nanjing…
  • Microecological, Regenerative and Microfabrication Technical Platform for Biomedicine and Tissue Engineering Jinan Microecological Biomedicine Shandong Laboratory Jinan City China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhuang, Y., Liu, K., He, Q., Gu, X., Jiang, C., & Wu, J. (2023). Hypoxia signaling in cancer: Implications for therapeutic interventions. MedComm, 4(1). https://doi.org/10.1002/mco2.203

Vancouver

Zhuang Y, Liu K, He Q, Gu X, Jiang C, Wu J. Hypoxia signaling in cancer: Implications for therapeutic interventions. MedComm. 2023;4(1). doi:10.1002/mco2.203

BibTeX
@article{Zhuang2023,
  author = {Zhuang, Yan and Liu, Kua and He, Qinyu and Gu, Xiaosong and Jiang, Chunping and Wu, Junhua},
  title = {Hypoxia signaling in cancer: Implications for therapeutic interventions},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {1},
  doi = {10.1002/mco2.203}
}
Kostenlos starten →